These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18308778)

  • 21. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
    Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M; Kuwilsky A; Krumm B; Dressing H
    J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is a high dosage aripiprazole-clozapine combination an effective strategy for treatment-resistant schizophrenic patients? A case report.
    Pigato G; Toffanin T; Perini GI
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):153-5. PubMed ID: 18801403
    [No Abstract]   [Full Text] [Related]  

  • 24. Aripiprazole: new drug. Just another neuroleptic.
    Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerability of high-dose aripiprazole in treatment-refractory schizophrenic patients.
    Crossman AM; Lindenmayer JP
    J Clin Psychiatry; 2006 Jul; 67(7):1158-9. PubMed ID: 16889465
    [No Abstract]   [Full Text] [Related]  

  • 26. [Efficacy of aripiprazole for the treatment of schizophrenia: what dose is required?].
    Charpeaud T; Samalin L; Llorca PM
    Encephale; 2014 Feb; 40(1):62-73. PubMed ID: 24445245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.
    Tseng PT; Chang YC; Chang CH; Wang HY; Cheng YS; Wu CK; Chen YW; Chung W
    Int J Psychiatry Med; 2015; 49(1):35-43. PubMed ID: 25838319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Who responds to aripiprazole in clinical practice? An observational study of combination versus monotherapy.
    Shajahan P; Macrae A; Bashir M; Taylor M
    J Psychopharmacol; 2008 Sep; 22(7):778-83. PubMed ID: 18308790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia".
    Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y
    J Clin Psychopharmacol; 2011 Jun; 31(3):400-1; author reply 401. PubMed ID: 21532377
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful switch from clozapine to aripiprazole: a case report.
    Jong-Yih L
    J Clin Psychopharmacol; 2009 Feb; 29(1):93-5. PubMed ID: 19142120
    [No Abstract]   [Full Text] [Related]  

  • 31. [No rebound psychosis in a case of switching from clozapine to quetiapine].
    Walther S; Baciu D
    Psychiatr Prax; 2006 Mar; 33(2):93-4. PubMed ID: 16502388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clozapine augmented with aripiprazole in 5 patients with schizophrenia.
    Abu-Tair F; Kopitz J; Bergemann N
    J Clin Psychopharmacol; 2006 Dec; 26(6):669-71. PubMed ID: 17110831
    [No Abstract]   [Full Text] [Related]  

  • 33. [Present data and treatment schedule of aripiprazole in the treatment of schizophrenia].
    Limosin F; Azorin JM; Krebs MO; Millet B; Glikman J; Camus V; Crocq MA; Costentin J; Daléry J
    Encephale; 2008 Jan; 34(1):82-92. PubMed ID: 18514155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive aripiprazole decreased metabolic side effects of clozapine treatment.
    Masopust J; Tůma I; Libiger J
    Neuro Endocrinol Lett; 2008 Aug; 29(4):435-7. PubMed ID: 18766167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clozapine augmentation with aripiprazole for negative symptoms.
    Clarke LA; Lindenmayer JP; Kaushik S
    J Clin Psychiatry; 2006 Apr; 67(4):675-6. PubMed ID: 16669737
    [No Abstract]   [Full Text] [Related]  

  • 36. A case report of partial bowel obstruction after aripiprazole addition to clozapine in a young male with schizophrenia.
    Legrand G; May R; Richard B; Kernisant M; Jalenques I
    J Clin Psychopharmacol; 2013 Aug; 33(4):571-2. PubMed ID: 23775055
    [No Abstract]   [Full Text] [Related]  

  • 37. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
    Azorin JM; Spiegel R; Remington G; Vanelle JM; Péré JJ; Giguere M; Bourdeix I
    Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is rational antipsychotic polytherapy feasible? A selective review.
    Kroken RA; Johnsen E
    Curr Psychiatry Rep; 2012 Jun; 14(3):244-51. PubMed ID: 22415638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism.
    Naber D; Lambert M
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1213-9. PubMed ID: 15588748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.
    Keck PE
    J Clin Psychiatry; 2005; 66 Suppl 3():5-11. PubMed ID: 15762829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.